Terns Pharmaceuticals logo

Terns Pharmaceuticals

Terns Pharmaceuticals is a small Molecules - Liver focus founded in 2017.

2

Funding Rounds

$167.0m

Money raised

Overview

Terns Pharmaceuticals is a small Molecules - Liver focus founded in 2017.

Funding series

Funding Series Analysis

The company Terns Pharmaceuticals has raised a total of $80m in funding over 2 rounds.

Key Insights:

  • Terns Pharmaceuticals Series B round, October 2018: $80m
  • Terns Pharmaceuticals Series C round January 2021: $87m
Terns Pharmaceuticals logo
Terns Pharmaceuticals Series B round, October 2018 $80m
Terns Pharmaceuticals logo
Terns Pharmaceuticals Series C round January 2021 $87m

Industries

Terns Pharmaceuticals is active in the following industries:
  • Technology
  • Biopharmaceutical
  • Biology
  • Engineering
  • Biomedical engineering
  • Biotechnology